Overall survival with daratumumab, lenalidomide, and dexamethasone in previously treated multiple myeloma (POLLUX): a randomized, open-label, phase III trial
by Dimopoulos, Meletios A. (Author)
, Oriol, Albert (Author)
, Nahi, Hareth (Author)
, San-Miguel, Jesus (Author)
, Bahlis, Nizar J. (Author)
, Usmani, Saad Z. (Author)
, Rabin, Neil (Author)
, Orlowski, Robert Z. (Author)
, Suzuki, Kenshi (Author)
, Plesner, Torben (Author)
, Yoon, Sung-Soo (Author)
, Ben Yehuda, Dina (Author)
, Richardson, Paul G. (Author)
, Goldschmidt, Hartmut (Author)
, Reece, Donna (Author)
, Ahmadi, Tahamtan (Author)
, Qin, Xiang (Author)
, Garvin Mayo, Wendy (Author)
, Gai, Xue (Author)
, Carey, Jodi (Author)
, Carson, Robin (Author)
, Moreau, Philippe (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource